Caro Named Beckman Coulter Group Vice President, Diagnostics Development Centers and Strategic Marketing.Business Editors/Health & Medical Writers FULLERTON, Calif.--(BUSINESS WIRE)--Aug. 24, 2001 Beckman Coulter This article needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. , Inc. (NYSE NYSE See: New York Stock Exchange :BEC) today announced it has appointed Elias Caro to the newly created position of group vice president for the company's Clinical Diagnostics product development centers and strategic marketing activities. Caro, who currently serves as vice president for Beckman Coulter's Hematology Development Center, has been promoted to oversee development activities for hematology, clinical chemistry and immunodiagnostics products. This includes establishing and maintaining collaborative relationships with the scientific community. The new group vice president, who reports to Albert Ziegler, president of the Clinical Diagnostics Division, will also be responsible for the activities of the worldwide strategic marketing team. "Bringing product development and strategic marketing together under a single individual provides for more internal alignment to meet customer needs for total testing solutions worldwide," said Ziegler. "Elias has both the global knowledge and breadth of experience in the clinical diagnostics industry to quickly help us realize the benefits of this new position and structure." Caro started his career with what was, at the time, Coulter Corporation in 1985 as general manager in Venezuela. Over the next 12 years, he continued his international management involvement, serving as general manager in Puerto Rico Puerto Rico (pwār`tō rē`kō), island (2005 est. pop. 3,917,000), 3,508 sq mi (9,086 sq km), West Indies, c.1,000 mi (1,610 km) SE of Miami, Fla. , assistant general manager in France, general manager of the Coordination Center in Belgium, and general manager/president in Japan. In 1997, the year Beckman Instruments, Inc. acquired Coulter, Caro moved to Miami as corporate director of Information Technology, then stepped into the position of vice president-director, Program Management and Quality Assurance for the Cellular Analysis Development Center. He was named to his most recent position as vice president, Cellular Analysis Development Center in early 1999. Caro earned both his bachelor of science Noun 1. Bachelor of Science - a bachelor's degree in science BS, SB bachelor's degree, baccalaureate - an academic degree conferred on someone who has successfully completed undergraduate studies degree in Industrial Engineering, with a minor in Information Systems, and his MBA MBA abbr. Master of Business Administration Noun 1. MBA - a master's degree in business Master in Business, Master in Business Administration from the Universidad de los Andes Universidad de Los Andes (Spanish: "University of the Andes") may refer to:
n. An academic degree conferred by a college or university upon those who complete at least one year of prescribed study beyond the bachelor's degree. Noun 1. in Polymer Science at the University of Akron Enrollment in fall 2006 was 23,539 students.[1] The school offers more than 200 undergraduate degrees [2] and 100 graduate degrees [3]. The University's best-known program is its College of Polymer Science and Polymer Engineering, which is located in a , Ohio. He and his family are in the process of moving to Orange County. Beckman Coulter, Inc. is a leading provider of instrument systems and complementary products that simplify and automate processes in life science and clinical laboratories. The company's products are used throughout the world in all phases of the battle against disease, from pioneering medical research and drug discovery to diagnostic testing Diagnostic testing Testing performed to determine if someone is affected with a particular disease. Mentioned in: Von Willebrand Disease that aids in patient treatment. Annual sales for the company totaled $1.89 billion in 2000, with approximately half of this amount generated outside the United States. More information on the company is available at www.beckmancoulter.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion